Literature DB >> 11033759

Medical approaches to primary hyperparathyroidism.

G J Strewler1.   

Abstract

Medical therapy is useful in cases of acute primary hyperparathyroidism, patients with recurrent disease, and parathyroid carcinoma. Among the therapeutic agents that have been employed, oral phosphate, bisphosphonates, and estrogens have been successful. The newly described calcimimetic agents directly block secretion of parathyroid hormone from the glands and offer an important new approach to medical therapy of primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033759     DOI: 10.1016/s0889-8529(05)70149-3

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism.

Authors:  Svante Jansson; Eric Morgan
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

2.  Abnormal bone scintigraphy and acute-onset severe primary hyperparathyroidism.

Authors:  L dell'Erba; S Palermo; E Orunesu; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 3.  Persistent and recurrent hyperparathyroidism.

Authors:  Nadine R Caron; Cord Sturgeon; Orlo H Clark
Journal:  Curr Treat Options Oncol       Date:  2004-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.